Laparoscopic Cholecystectomy Care Protocol


The purpose of this study is to determine compliance with the Prisma Health-Upstate Laparoscopic Cholecystectomy Perioperative Protocol.

Full Title of Study: “Compliance With Laparoscopic Cholecystectomy Care Protocol”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: April 1, 2017

Detailed Description

Evidence based medicine calls for the application of scientific advances to clinical care. In an effort to address the most common complications of a surgical procedure, perioperative protocols have recently been created in an effort to apply best practices consistently and enhance the recovery from surgery. In addition to evaluating the validity of the protocol components themselves, it is valuable to measure compliance with said protocol. Failure to complete the steps of a care pathway may be caused by several reasons, and a study of application of these steps may help future efforts at standardization of care.

The purpose of this study is to determine compliance with the Prisma Health-Upstate Laparoscopic Cholecystectomy Perioperative Protocol.

Hospital inpatient data from patient charts, office charts, and hospital medical data systems of Prisma Health-Upstate System will be used to review the records of all patients age 18-75 years, inpatient and outpatient, who had surgery for choledocolithiasis between January 1, 2016 to April 1, 2017.


  • Other: Protocol Compliance
    • Compliance with the Prisma Health-Upstate Laparoscopic Cholecystectomy Perioperative Protocol

Clinical Trial Outcome Measures

Primary Measures

  • Protocol Compliance
    • Time Frame: 15 months
    • Percent compliance with protocol components

Secondary Measures

  • Length of Stay
    • Time Frame: 15 months
    • Post acute care unit length of stay will be measured in minutes

Participating in This Clinical Trial

Inclusion Criteria

  • Patients between the ages of 18 years and 75 years who had surgery for choledocholithiasis at Prisma Health-Upstate.

Exclusion Criteria

  • Patients under 18 years of age and older than 75 years of age.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 75 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Prisma Health-Upstate
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • William Hand, MD, Principal Investigator, Prisma Health-Upstate

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.